ACLX Q1 2023 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M

Gross Profit

$17M95.9% margin

Operating Income

-$30M-170.0% margin

Net Income

-$27M-152.7% margin

EPS (Diluted)

$-0.58

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

$182M

Free Cash Flow

$181M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$623M

Total Liabilities

$319M

Stockholders' Equity

$304M

Cash & Equivalents

$275M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$0	—
Gross Profit	$17M	$0	—
Operating Income	-$30M	-$26M	-16.7%
Net Income	-$27M	-$26M	-5.0%